These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Th22 cell accumulation is associated with colorectal cancer development. Huang YH; Cao YF; Jiang ZY; Zhang S; Gao F World J Gastroenterol; 2015 Apr; 21(14):4216-24. PubMed ID: 25892871 [TBL] [Abstract][Full Text] [Related]
3. High expression of interleukin-22 and its receptor predicts poor prognosis in pancreatic ductal adenocarcinoma. Wen Z; Liao Q; Zhao J; Hu Y; You L; Lu Z; Jia C; Wei Y; Zhao Y Ann Surg Oncol; 2014 Jan; 21(1):125-32. PubMed ID: 24132627 [TBL] [Abstract][Full Text] [Related]
4. Increased intratumoral interleukin 22 levels and frequencies of interleukin 22-producing CD4+ T cells correlate with pancreatic cancer progression. Xu X; Tang Y; Guo S; Zhang Y; Tian Y; Ni B; Wang H Pancreas; 2014 Apr; 43(3):470-7. PubMed ID: 24622082 [TBL] [Abstract][Full Text] [Related]
5. Increased intratumoral IL-22-producing CD4(+) T cells and Th22 cells correlate with gastric cancer progression and predict poor patient survival. Zhuang Y; Peng LS; Zhao YL; Shi Y; Mao XH; Guo G; Chen W; Liu XF; Zhang JY; Liu T; Luo P; Yu PW; Zou QM Cancer Immunol Immunother; 2012 Nov; 61(11):1965-75. PubMed ID: 22527243 [TBL] [Abstract][Full Text] [Related]
6. Prevailing role of contact guidance in intrastromal T-cell trapping in human pancreatic cancer. Hartmann N; Giese NA; Giese T; Poschke I; Offringa R; Werner J; Ryschich E Clin Cancer Res; 2014 Jul; 20(13):3422-33. PubMed ID: 24763614 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. Liyanage UK; Moore TT; Joo HG; Tanaka Y; Herrmann V; Doherty G; Drebin JA; Strasberg SM; Eberlein TJ; Goedegebuure PS; Linehan DC J Immunol; 2002 Sep; 169(5):2756-61. PubMed ID: 12193750 [TBL] [Abstract][Full Text] [Related]
8. ESAT-6- and CFP-10-specific Th1, Th22 and Th17 cells in tuberculous pleurisy may contribute to the local immune response against Mycobacterium tuberculosis infection. Qiao D; Yang BY; Li L; Ma JJ; Zhang XL; Lao SH; Wu CY Scand J Immunol; 2011 Apr; 73(4):330-7. PubMed ID: 21223348 [TBL] [Abstract][Full Text] [Related]
9. Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes. Nonaka K; Saio M; Suwa T; Frey AB; Umemura N; Imai H; Ouyang GF; Osada S; Balazs M; Adany R; Kawaguchi Y; Yoshida K; Takami T J Leukoc Biol; 2008 Sep; 84(3):679-88. PubMed ID: 18566103 [TBL] [Abstract][Full Text] [Related]
10. DKK2 Impairs Tumor Immunity Infiltration and Correlates with Poor Prognosis in Pancreatic Ductal Adenocarcinoma. Yang J; Jiang Y; He R; Liu W; Yang M; Tao L; Fu X; Shen Y; Li J; Liu D; Huo Y; Zhang J; Hua R; Zhang Z; Sun Y J Immunol Res; 2019; 2019():8656282. PubMed ID: 31583260 [TBL] [Abstract][Full Text] [Related]
11. Anergic natural killer cells educated by tumor cells are associated with a poor prognosis in patients with advanced pancreatic ductal adenocarcinoma. Yang C; Cheng H; Zhang Y; Fan K; Luo G; Fan Z; Huang Q; Lu Y; Jin K; Wang Z; Yu X; Liu C Cancer Immunol Immunother; 2018 Dec; 67(12):1815-1823. PubMed ID: 30167864 [TBL] [Abstract][Full Text] [Related]
12. Intratumoral CD38 Zhu H; Xu J; Wang W; Zhang B; Liu J; Liang C; Hua J; Meng Q; Yu X; Shi S EBioMedicine; 2024 May; 103():105098. PubMed ID: 38608514 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of immune factors in the tumor microenvironment of patients with pancreatic ductal adenocarcinoma. Kiryu S; Ito Z; Suka M; Bito T; Kan S; Uchiyama K; Saruta M; Hata T; Takano Y; Fujioka S; Misawa T; Yamauchi T; Yanagisawa H; Sato N; Ohkusa T; Sugiyama H; Koido S BMC Cancer; 2021 Nov; 21(1):1197. PubMed ID: 34758773 [TBL] [Abstract][Full Text] [Related]
14. Tumor-neuroglia interaction promotes pancreatic cancer metastasis. Su D; Guo X; Huang L; Ye H; Li Z; Lin L; Chen R; Zhou Q Theranostics; 2020; 10(11):5029-5047. PubMed ID: 32308766 [No Abstract] [Full Text] [Related]
15. miR-128 Regulates Tumor Cell CD47 Expression and Promotes Anti-tumor Immunity in Pancreatic Cancer. Xi Q; Chen Y; Yang GZ; Zhang JY; Zhang LJ; Guo XD; Zhao JY; Xue ZY; Li Y; Zhang R Front Immunol; 2020; 11():890. PubMed ID: 32536914 [TBL] [Abstract][Full Text] [Related]
16. Infiltrating immune cells and gene mutations in pancreatic ductal adenocarcinoma. Wang WQ; Liu L; Xu HX; Wu CT; Xiang JF; Xu J; Liu C; Long J; Ni QX; Yu XJ Br J Surg; 2016 Aug; 103(9):1189-99. PubMed ID: 27256393 [TBL] [Abstract][Full Text] [Related]
17. Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma. Jin A; Xu Y; Liu S; Jin T; Li Z; Jin H; Lin L; Lin Z Exp Mol Pathol; 2014 Feb; 96(1):54-60. PubMed ID: 24263054 [TBL] [Abstract][Full Text] [Related]
18. Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progression. Alam MS; Gaida MM; Bergmann F; Lasitschka F; Giese T; Giese NA; Hackert T; Hinz U; Hussain SP; Kozlov SV; Ashwell JD Nat Med; 2015 Nov; 21(11):1337-43. PubMed ID: 26479921 [TBL] [Abstract][Full Text] [Related]
19. The predictive value and role of stromal tumor-infiltrating lymphocytes in pancreatic ductal adenocarcinoma (PDAC). Lianyuan T; Dianrong X; Chunhui Y; Zhaolai M; Bin J Cancer Biol Ther; 2018 Apr; 19(4):296-305. PubMed ID: 29313457 [TBL] [Abstract][Full Text] [Related]
20. The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implications. Liu X; Xu J; Zhang B; Liu J; Liang C; Meng Q; Hua J; Yu X; Shi S Mol Cancer; 2019 Dec; 18(1):184. PubMed ID: 31831007 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]